5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）用于胃肠道癌患者。 - Suppr | 超能文献

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.

作者信息

Moertel C G, Reitemeier R J, Hahn R G, Schutt A J

出版信息

Cancer Chemother Rep. 1970 Dec;54(6):471-3.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）用于胃肠道癌患者。

Cancer Chemother Rep. 1970 Dec;54(6):471-3.

2

Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).使用抗肿瘤药物5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）的临床试验。

Cancer Chemother Rep. 1970 Apr;54(2):119-24.

3

5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.

Cancer Chemother Rep. 1972 Aug;56(4):523-6.

4

Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.

Cancer. 1972 Sep;30(3):654-9. doi: 10.1002/1097-0142(197209)30:3<654::aid-cncr2820300312>3.0.co;2-x.

5

Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide.阿霉素与二甲基三氮烯咪唑甲酰胺联合用于肉瘤的化疗。

Cancer. 1972 Dec;30(6):1632-8. doi: 10.1002/1097-0142(197212)30:6<1632::aid-cncr2820300632>3.0.co;2-s.

6

[Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].[采用5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺（达卡巴嗪；NSC-45388）、1,3-双(2-氯乙基)-1-亚硝基脲（卡莫司汀，NSC-409962）和长春新碱（NSC-67574）对黑色素瘤转移期进行多药化疗]

Tumori. 1973 May-Jun;59(3):239-48. doi: 10.1177/030089167305900305.

7

Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.5-（3,3-双（2-氯乙基）-1-三氮烯基）咪唑-4-甲酰胺（NSC-82196）治疗转移性恶性黑色素瘤的临床经验

Cancer Chemother Rep. 1972 Oct;56(5):671-7.

8

5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.

Eur J Cancer (1965). 1972 Feb;8(1):85-92. doi: 10.1016/0014-2964(72)90087-4.

9

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.

Cancer Chemother Rep. 1971 Jun;55(3):281-3.

10

Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer.氟尿嘧啶、咪唑甲酰胺二甲基三氮烯、长春新碱和双氯乙基亚硝脲用于结肠癌治疗

Cancer. 1974 May;33(5):1207-9. doi: 10.1002/1097-0142(197405)33:5<1207::aid-cncr2820330502>3.0.co;2-9.

引用本文的文献

1

A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.达卡巴嗪联合自体骨髓移植治疗实体瘤患者的I期临床及药理学研究

Invest New Drugs. 1993 May-Aug;11(2-3):169-79. doi: 10.1007/BF00874151.

2

[Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].13种芳基二烷基三氮烯对BD大鼠的致癌活性（作者译）

Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974;81(3-4):285-310. doi: 10.1007/BF00305031.